Development of Mithramycin Analogs for Ewing sarcoma |
Van Andel Research Institute / Patrick Grohar, MD/PhD |
Innovation Grants |
2017 |
Michigan |
De-escalation of Radiotherapy for Medulloblastoma by a Novel DNA Damage Checkpoint Inhibitor |
Feinstein Institute for Medical Research - North Shore / Marc Symons, PhD |
Innovation Grants |
2017 |
New York |
Targeting Metabolic Vulnerabilities in ETP-ALL |
Columbia University / Adolfo A. Ferrando, MD/PhD |
Innovation Grants |
2017 |
New York |
Long Non-Coding RNAs as Novel Biomarkers and Therapeutic Targets in Pediatric Leukemia |
New York University School of Medicine / Iannis Aifantis, PhD |
Innovation Grants |
2017 |
New York |
Predictive Modeling of MDS Disease Progression From Inherited Bone Marrow Failure Syndrome Using Novel Branching Process and Next Generation Sequencing to Improve Patient-Specific Survival |
Cleveland Clinic Foundation / Seth Corey, MD & Marek Kimmel, PhD |
Innovation Grants |
2017 |
Ohio |
Targeting Pediatric Brain Tumors Using PTPmu Nanochains with Radiofrequency-Releasable Therapeutics |
Case Western Reserve University / Susann Brady-Kalnay, PhD & Efstathios Karathanasis, PhD |
Innovation Grants |
2017 |
Ohio |
Alternative Splicing in the Pathogenesis of Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia / Andrei Thomas-Tikhonenko, PhD |
Innovation Grants |
2017 |
Pennsylvania |
Defining the Cell Surface Landscape of Diagnostic and Relapsed Neuroblastoma: Immunotherapeutic Target Identification |
Children’s Hospital of Philadelphia / Sharon Diskin, PhD |
Innovation Grants |
2017 |
Pennsylvania |
Establishing the Function of Novel MicroRNAs Associated with Resistance and Relapse in Pediatric AML |
Fred Hutchinson Cancer Research Center / Vivian Oehler, MD & Soheil Meshinchi, MD/PhD |
Innovation Grants |
2017 |
Washington |